XML 27 R16.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK COMPENSATION
12 Months Ended
Dec. 31, 2024
STOCK COMPENSATION  
STOCK COMPENSATION

8. STOCK COMPENSATION

 

On October 13, 2016, the Board of Directors of the Company adopted the 2016 Equity Incentive Plan, which allows the Company to grant up to 400,000 shares of restricted common stock of the Company to employees, officers, directors and consultants and 89,303 share remain available to be granted as of December 31, 2024. The grants may be in the form of restricted or performance shares of common stock of the Company.

 

The fair value of restricted stock awards is estimated to be the market price of the Company's common stock at the close of date of grant. The Company assumes no forfeitures as they are granted to key executives and board members.

 

Restricted stock activity during the years ended December 31, 2024 is as follows:

 

 

 

Performance-Based

 

 

Service-Based

 

 

Number of Shares

 

 

Weighted Average Grant Date Fair Value per Share

 

Non-vested, December 31, 2023

 

 

40,278

 

 

 

2,000

 

 

 

42,278

 

 

$12.07

 

Granted

 

 

767

 

 

 

 

 

 

767

 

 

 

11.72

 

Vested

 

 

(37,205)

 

 

(1,000 )

 

 

(38,205)

 

 

11.72

 

Settlement of restricted stock

 

 

(3,840)

 

 

 

 

 

(3,840)

 

 

37.12

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-vested, December 31, 2024

 

 

 

 

 

1,000

 

 

 

1,000

 

 

$19.15

 

 

In 2021, the Compensation Committee and Board of Directors approved a Long-Term Incentive Plan with respect to the grant of stock pursuant to the 2016 Equity Incentive Plan. The final equity amount earned was based on continued service through the three-year performance period ending on December 31, 2023, Board discretion, and performance results. The actual number of performance-based shares of common stock of the Company, if any, earned by the award recipients was determined based on measures that include Earnings Before Interest Taxes Depreciation and Amortization (“EBITDA”) margin, revenue growth, and free cash flow. The EBITDA margin and revenue growth performance targets were set for each of the Minimum, Target, and Maximum levels. In May 2024, the actual performance amount (in thousands) was determined by the Compensation Committee to be $579. The stock compensation cost was recognized over the requisite performance/service period using the straight-line method and based on the probable number of shares to be awarded. During the second quarter of 2024 an additional expense amount (in thousands) of $25 was recorded related to the final amount awarded by the Compensation Committee.

 

Awards are being amortized to expense ratably, based upon the vesting schedule. Stock compensation expense (in thousands) for the years ended December 31, 2024 and 2023 was approximately $45 and $375, respectively, based upon the value at the date of grant. The Company recognized tax benefits (in thousands) of $175 and $9 related to stock compensation expense for the years ended December 31, 2024 and 2023, respectively. The fair value of the shares vested (in thousands) for the years ended December 31, 2024 and 2023 was $19 and $221, respectively, based upon the value at the date of vesting. There was $14 thousand of unrecognized compensation cost related to the non-vested restricted stock as of December 31, 2024 and will be recognized ratably over a 9 month period. All non-vested restricted vests and is earned based on continued service of the award recipients.